Navigation Links
WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release
Date:7/19/2011

SHANGHAI, July 19, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2011 after the New York Stock Exchange closes on Wednesday, August 10, 2011 (which will be Thursday morning, August 11, 2011 Shanghai time). The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com.

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Thursday, August 11, 2011, to discuss the second-quarter 2011 financial results and recent business activities. The conference call may be accessed by calling:United States:

1-866-519-4004China (Landline):

800-819-0121China (Mobile):

400-620-8038Hong Kong:

800-930-346United Kingdom:

0-808-234-6646International:

+65-6723-9381Conference ID:

83583576A telephone replay will be available two hours after the call's completion at:

United States:

1-866-214-5335China North:

10-800-714-0386China South:

10-800-140-0386Hong Kong:

800-901-596United Kingdom:

0-800-731-7846International:

+61-2-8235-5000Conference ID:

83583576A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com.

About WuXi PharmaTechWuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

For more information, please contact:

Ronald AldridgeDirector of Investor RelationsWuXi PharmaTech (Cayman) Inc.Tel: +1-201-585-2048Email: Ron_Aldridge@wuxiapptec.comWeb: http://www.wuxiapptec.com
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
3. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
5. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
7. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
8. WuXi PharmaTech Announces First-Quarter 2010 Results
9. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
10. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
11. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... LITTLE FALLS, N.J. , Jan. 18, 2017 /PRNewswire/ ... RGIN ), a biotechnology company specializing in the development ... health of damaged tissues and organs, recently reported the ... key milestones for 2017. As the Company ... 2016 has been a year of substantial accomplishments. The ...
(Date:1/18/2017)... Research and Markets has announced the addition of the "Global ... offering. ... global CINV drugs market to grow at a CAGR of 5.41% ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. To calculate the market ...
(Date:1/18/2017)... 2017 The report " Automated Breast Ultrasound System (ABUS) ... By End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional Outlook (U.S., ... , Germany , UK, France , ... , China , Japan , ... , Saudi Arabia , UAE, South Africa ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... ... and most-read publication among specialty pharmacists and pharmacy professionals, has teamed up ... Alliance Partnership (SAP) program, announced Brian Haug, president of Pharmacy Healthcare Communications, ...
(Date:1/18/2017)... ... 2017 , ... The Portee Insurance Agency, a family managed firm that offers ... and the DC region, is inaugurating a charity event aimed at fighting heart disease ... it the #1 killer in America. However, heart disease is largely preventable, and a ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... presenting at the upcoming WCBP Conference, to be held at the Mayflower Hotel, ...
(Date:1/18/2017)... ... January 18, 2017 , ... During ... disease to enamel erosion, and those dental problems can increase the risk of ... many pregnant women are failing to get the dental care they need. Agoura ...
(Date:1/17/2017)... ... ... Gym Source, America’s leading retailer of premium residential and commercial fitness equipment, ... FL. , “We are elated to be opening this new showroom,” explains Tom Richard, ... give clients a seamless and motivating shopping experience.” , Every fitness journey is unique, ...
Breaking Medicine News(10 mins):